Drugs / clavulinic acid
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00649831 Comparator | Oct 2002 → Jun 2003 | chronic bronchitis | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | clavulinic acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00649831 ↗ |
| Route | Oral | “amoxicillin/clavulinic acid 500 mg/62.5 mg tablet; take 2 tablets by mouth twice daily (BID) for 10 days” NCT00649831 ↗ |